4000 Wellness Drive
Midland, MI 48670
General Information
Objectives
-
Relate the effect of the Mainstreaming Addiction Treatment Act and the DEA 30-day post teleprescribing rule on buprenorphine access, nationally and in Michigan.
-
Describe common barriers encountered by patients and pharmacists when filling buprenorphine prescriptions for OUD.
-
Identify specific strategies for resolving pharmacy-level barriers to buprenorphine access, including interprofessional collaboration and patient communication.
Presentations and Speakers
Available Credits/Points
Disclosure Statements
Accreditation Statement
Test Information